A study published in JSCAI found that patients with type 1 diabetes have a lower risk of cardiovascular events than those with type 2 diabetes, with potential implications for treatment strategies.
Analysis of the Veradigm Metabolic Registry, which includes records of 1.5 million individuals, revealed that type 1 diabetes patients had lower rates of myocardial infarction, stroke, percutaneous coronary intervention, and limb ischemia compared to those with type 2 diabetes. However, the frequency of coronary artery bypass grafting did not differ significantly between the two groups.
Dr. Andrew Goldsweig of Baystate Medical Centre states, “Our study shows that type 1 diabetes is associated with a significantly lower risk of cardiovascular events, even after adjusting for factors such as age, diabetes control, and kidney function.” These findings suggest the need for distinct therapeutic approaches for different forms of diabetes.
Dr. Bracha Goldsweig emphasized the importance of disease-specific treatment strategies: “Type 1 and type 2 diabetes are fundamentally different diseases. Our results show that patients with type 1 diabetes must develop separate therapeutic approaches to optimize their health.” The study highlights the role of interdisciplinary collaboration in endocrinology and cardiology to refine treatment approaches and improve patient outcomes.
